Thrombolysis Safe for Stroke Patients on DOACs?

The largest study to date to look at this issue has actually found a lower rate of symptomatic intracerebral hemorrhage in patients on DOACs receiving thrombolysis than those not taking anticoagulants.

Related Keywords

University Of Cincinnati ,Ohio ,United States ,Bern ,Switzerland ,Davidj Seiffge ,Evaa Mistry , ,Bern University Hospital ,Stroke ,Erebrovascular Accident ,Va Cerebrovascular Accident ,Thromboembolism ,Hypertension ,Anticoagulation Therapy ,Anticoagulant ,Anticoagulation ,Clinical Guidelines ,Guidelines ,Hemorrhage ,Bleeding ,Intracerebral Hemmorhage ,Hospitals ,Blood Brain Barrier Bbb ,Factor Ii ,Lotting Factor Ii ,Prothrombin ,Thrombin ,Ctivated Factor Ii ,Ctivated Factor Iia ,Grant ,Ischemic Stroke ,Thrombolytic Thera ,